Main competitors
Add to a list
1m. EPS revision 1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Divergence of Estimates Nbr of analysts
19
25
26
22
27
26
20
20
24
22
22
27
21
21
15
16
17
18
15
Average 21
Weighted average by Cap. 23
Other Pharmaceuticals
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW